Lewis B. Silverman

Columbia University Irving Medical Center — United States

Medicine · Health Sciences

82h-index28.1kcitations487works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(366), Childhood Cancer Survivors' Quality of Life(191), Acute Myeloid Leukemia Research(93), Chronic Lymphocytic Leukemia Research(49), Chronic Myeloid Leukemia Treatments(49)

Publications487 total

Safety and efficacy of direct oral anticoagulants in pediatric oncology patients: real-world data from two quaternary care pediatric centers
Research and Practice in Thrombosis and Haemostasis·2026Open Access
Outcomes of T-cell lymphoblastic lymphoma in children and adolescents treated with Dana-Farber Cancer Institute Childhood ALL Consortium protocols
Frontiers in Pediatrics·2026Open Access
Trajectory of Neurocognitive Functioning in Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana‐Farber Cancer Institute ALL Consortium Study 16‐001
Pediatric Blood & Cancer·2026Open Access
Philadelphia chromosome‐positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challenge
British Journal of Haematology·2025Open Access
Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemia
Nature Communications·2025Open Access
Supplementary Figure 1 from Treatment-Related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration during Therapy for Childhood Acute Lymphoblastic Leukemia
2025Open Access
Germline predisposition in pediatric malignancies: Insights from a retrospective study at Dana-Farber Cancer Institute
Blood·2025
Supplementary Figure 2 from Treatment-Related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration during Therapy for Childhood Acute Lymphoblastic Leukemia
2025Open Access
Comparison of paired bone marrow and peripheral blood measurable residual disease in pediatric acute lymphoblastic leukemia by next-generation sequencing: A report from the dana farber ALL consortium protocol 16-001.
Blood·2025Open Access
Outcome of children and adolescents with newly diagnosed T-cell acute lymphoblastic leukemia: Results of DFCI ALL consortium protocol 16-001
Blood·2025Open Access
Supplementary Table 1 from Treatment-Related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration during Therapy for Childhood Acute Lymphoblastic Leukemia
2025Open Access
Data from Treatment-Related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration during Therapy for Childhood Acute Lymphoblastic Leukemia
2025Open Access
Cumulative incidence of household material hardship and income loss as measures of financial toxicity during pediatric acute lymphoblastic leukemia (ALL) treatment: A report from the DFCI ALL 16-001 Trial
Blood·2025Open Access
Safety and effectiveness of standard versus extended duration of anticoagulation in children with acute lymphoblastic leukemia and venous thrombo-embolism
Blood·2025Open Access
Treatment-Related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration during Therapy for Childhood Acute Lymphoblastic Leukemia
Cancer Epidemiology Biomarkers & Prevention·2025· 1 citedOpen Access
Comparative analysis of plasma and bone marrow nutrient levels in pediatric B-ALL patients
2025Open Access
Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia
JAMA Network Open·2025· 3 citedOpen Access
Baseline Neurocognitive Functioning Among Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana Farber Cancer Institute ALL Consortium Study 16‐001
Pediatric Blood & Cancer·2025· 1 cited
803: MULTIOMIC PROFILING OF LIPIDOMIC AND PROTEOMIC ASSOCIATIONS IN PATIENTS PRIOR TO DEVELOPING ASPARAGINASEASSOCIATED PANCREATITIS SIGNALS TO NOVEL DISEASE SIGNATURES
Gastroenterology·2025
Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial
Pediatric Blood & Cancer·2025Open Access
page 1 of 25Next →

Frequent Co-authors

Stephen E. Sallan(31), Donna Neuberg(17), Barbara L. Asselin(12), Luis A. Clavell(12), Marshall A. Schorin(11), Rob Pieters(10), Stephen P. Hunger(10), Martin Schrappe(10), Steven E. Lipshultz(8), Bruno Michon(8), Suzanne E. Dahlberg(8), Kristen E. Stevenson(8), A. Thomas Look(7), Ching‐Hon Pui(7), André Baruchel(7), Gabriele Escherich(7), Uma H. Athale(7), Harvey J. Cohen(7), Kara M. Kelly(7), Caroline Laverdière(7)